Home › Funds › Octagon Capital Advisors LP › PALI

Octagon Capital Advisors LP position in PALI

PALISADE BIO INC · Health Care

Octagon Capital Advisors LP reported holding 10,276,317 shares of PALI (PALISADE BIO INC) in its Q3 2026 13F filing — a position valued at US$13.9M, representing 1.85% of its reported portfolio and ranking #15 among its reported holdings. Octagon Capital Advisors LP has disclosed PALI holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)10.28M sh
Reported value held$13.87M
Portfolio Weight1.85%
First reportedQ4 2025
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Octagon Capital Advisors LP's PALI position evolved

Octagon Capital Advisors LP first disclosed a stake in PALI in Q4 2025 at 9,567,898 shares (US$22.5M). Across 4 filings, Octagon Capital Advisors LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 10,276,317 shares valued at US$13.9M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 9.57M $22.48M New
Q1 2026 10.28M $17.98M Add
Q2 2026 10.28M $21.48M Hold
Q3 2026 10.28M $13.87M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PALI and 13F data

PALI (PALISADE BIO INC) is a Health Care company. 75 other funds we track also report a position in PALI — the largest reported positions include Soleus Capital Management, L.P. (US$20.2M), B Group, Inc. (US$15.4M), Boxer Capital Management, LLC (US$6.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PALI

All PALI fund holders →

FAQ

How long has Octagon Capital Advisors LP held PALI?

Octagon Capital Advisors LP has disclosed PALI holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Octagon Capital Advisors LP's current position in PALI?

As of Q3 2026, Octagon Capital Advisors LP holds 10.28M shares of PALI (PALISADE BIO INC), valued at $13.87M, representing 1.85% of its reported portfolio and ranking #15.

Has Octagon Capital Advisors LP been buying or selling PALI?

In the latest 13F filing (Q3 2026), Octagon Capital Advisors LP held unchanged its position in PALI.

Which other funds hold PALI?

Other major institutional holders of PALI include Soleus Capital Management, L.P., B Group, Inc., Boxer Capital Management, LLC, among 75 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.